Stay up to date on New Jersey’s business landscape! Subscribe to our newsletter to receive updates, insights, and highlights directly to your inbox.
Powered by 
Translate
Tokyo, Japan — Governor Murphy and the New Jersey delegation participated in a business seminar, hosted by Japan External Trade Organization (JETRO), a Japanese government-related organization that promotes mutually beneficial trade and investment relations between Japan and […]
Hiroshima, Japan — Governor Murphy, First Lady Murphy, and the New Jersey Delegation visited the Hiroshima Peace Memorial Museum to pay respects and offer prayers for the thousands of people who lost their lives during the
Governor Murphy, First Lady, and New Jersey Delegation Pay Respect to Hiroshima Victims Read More »
Hiroshima, Japan — Governor Murphy met with Governor Ryuta Ibaragi to discuss the importance of building bilateral relationships between New Jersey and Japan. Governor Murphy emphasized that partnerships with our friends in Japan have never
Hiroshima, Japan — Following the Peace Memorial Park and Museum tour, Governor Murphy met with Hiroshima Mayor Matsui. The Mayor welcomed the New Jersey delegation and discussed how important it is to strengthen economic ties between
Governor Murphy and First Lady Tammy Murphy Meet Hiroshima Mayor Kazumi Matsui Read More »
Hiroshima, Japan — Governor Murphy, joined by Dr. Mitsuo Ochi, President of Hiroshima University, witnessed the signing of a historic Letter of Intent (LOI) between Rutgers University, RWJBarnabas Health, and Hiroshima University, a top public research
A record six schools placed in the Top 100 of the U.S. News & World Report Best Colleges ranking of national universities, which was released Monday and long has been considered the gold standard of college rankings.
A record 6 New Jersey universities made U.S. News’ Top 100 Universities list Read More »
For more than 135 years, Johnson & Johnson has provided health care products and solutions to people worldwide. Now, with its exclusive focus on healthcare innovation and tackling the toughest health challenges, the Company is
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish